Related Experiment Video
Updated: May 27, 2026

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
Published on: December 8, 2014
Approach to the patient with infectious colitis
1The University of Texas School of Public Health, St. Luke's Episcopal Hospital, Baylor College of Medicine and Kelsey Research Foundation, Houston, Texas, USA. Herbert.L.Dupont@uth.tmc.edu
Current guidelines recommend pathogen-specific antimicrobial therapy for infectious colitis, except for Shiga toxin-producing Escherichia coli (STEC). Empiric treatment for febrile dysenteric diarrhea includes azithromycin for invasive bacterial enteropathogens.
Area of Science:
- Gastroenterology
- Infectious Diseases
- Microbiology
Background:
- Infectious colitis presents with diarrhea and indicators like fever, dysentery, or inflammatory stool markers.
- Diagnosis involves identifying invasive or inflammatory bacterial enteropathogens via stool culture or endoscopy.
Purpose of the Study:
- To offer current recommendations for evaluating and treating patients diagnosed with infectious colitis.
- To guide clinicians in managing various causes of infectious colitis.
Main Methods:
- Standard stool cultures are essential for diagnosing infectious colitis.
- Specific diagnostic approaches are needed when Shiga toxin-producing E. coli (STEC) is suspected, requiring direct stool testing for E. coli O157:H7 and Shiga toxin.
- Epidemiological factors like travel history can inform the need for specialized etiological studies.
Main Results:
- Pathogen-specific antimicrobial therapy is recommended for all infectious colitis types, excluding STEC infections.
- In cases of febrile dysenteric diarrhea, invasive bacterial enteropathogens such as Shigella, Salmonella, and Campylobacter should be considered.
- Empiric treatment for adults with febrile dysenteric diarrhea may involve a single 1000mg dose of azithromycin.
Conclusions:
- Prompt laboratory diagnosis is crucial for initiating appropriate antimicrobial therapy.
- Tailoring treatment based on the identified pathogen ensures effective management of infectious colitis.
- Azithromycin serves as an effective empiric treatment option for specific bacterial enteropathogen-induced diarrheal illnesses.
Related Concept Videos
Transmission-based Precautions I: Contact, Enteric, and Droplets
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease II: Ulcerative Colitis
Inflammatory Bowel Disease I: Introduction
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease IV: Clinical Manifestations

